A detailed history of Forsta Ap Fonden transactions in Dexcom Inc stock. As of the latest transaction made, Forsta Ap Fonden holds 83,700 shares of DXCM stock, worth $6.7 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
83,700
Previous 71,800 16.57%
Holding current value
$6.7 Million
Previous $8.14 Million 31.09%
% of portfolio
0.04%
Previous 0.07%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

BUY
$64.0 - $116.06 $761,600 - $1.38 Million
11,900 Added 16.57%
83,700 $5.61 Million
Q2 2024

Aug 08, 2024

SELL
$110.31 - $140.45 $3.33 Million - $4.24 Million
-30,200 Reduced 29.61%
71,800 $8.14 Million
Q1 2024

May 07, 2024

BUY
$114.22 - $140.1 $868,072 - $1.06 Million
7,600 Added 8.05%
102,000 $14.1 Million
Q4 2023

Feb 06, 2024

SELL
$75.49 - $124.16 $211,372 - $347,648
-2,800 Reduced 2.88%
94,400 $11.7 Million
Q3 2023

Oct 25, 2023

SELL
$86.06 - $137.93 $172,120 - $275,860
-2,000 Reduced 2.02%
97,200 $9.07 Million
Q2 2023

Aug 03, 2023

BUY
$112.47 - $130.98 $2.49 Million - $2.89 Million
22,100 Added 28.66%
99,200 $12.7 Million
Q1 2023

Apr 21, 2023

SELL
$104.0 - $122.92 $1.4 Million - $1.66 Million
-13,500 Reduced 14.9%
77,100 $8.96 Million
Q4 2022

Feb 02, 2023

BUY
$84.98 - $122.67 $1.09 Million - $1.57 Million
12,800 Added 16.45%
90,600 $10.3 Million
Q3 2022

Oct 17, 2022

SELL
$76.35 - $94.18 $198,509 - $244,868
-2,600 Reduced 3.23%
77,800 $6.27 Million
Q2 2022

Aug 11, 2022

BUY
$67.99 - $132.89 $4.17 Million - $8.15 Million
61,300 Added 320.94%
80,400 $5.99 Million
Q1 2022

May 09, 2022

SELL
$94.08 - $130.2 $122,304 - $169,259
-1,300 Reduced 6.37%
19,100 $9.77 Million
Q4 2021

Feb 11, 2022

BUY
$129.87 - $162.82 $51,948 - $65,128
400 Added 2.0%
20,400 $11 Million
Q3 2021

Nov 10, 2021

SELL
$106.71 - $143.18 $320,130 - $429,540
-3,000 Reduced 13.04%
20,000 $10.9 Million
Q2 2021

Aug 12, 2021

BUY
$80.99 - $107.93 $275,366 - $366,962
3,400 Added 17.35%
23,000 $9.82 Million
Q1 2021

May 11, 2021

BUY
$84.79 - $104.74 $33,916 - $41,896
400 Added 2.08%
19,600 $7.04 Million
Q4 2020

Feb 09, 2021

BUY
$78.0 - $104.5 $483,600 - $647,900
6,200 Added 47.69%
19,200 $7.1 Million
Q3 2020

Oct 22, 2020

BUY
$95.51 - $112.95 $171,918 - $203,310
1,800 Added 16.07%
13,000 $5.36 Million
Q2 2020

Aug 11, 2020

BUY
$62.68 - $105.34 $18,804 - $31,602
300 Added 2.75%
11,200 $4.54 Million
Q1 2020

May 04, 2020

BUY
$47.79 - $75.63 $520,911 - $824,367
10,900 New
10,900 $2.94 Million

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $30.9B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Forsta Ap Fonden Portfolio

Follow Forsta Ap Fonden and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Forsta Ap Fonden, based on Form 13F filings with the SEC.

News

Stay updated on Forsta Ap Fonden with notifications on news.